AR095501A1 - RSV VACCINES - Google Patents
RSV VACCINESInfo
- Publication number
- AR095501A1 AR095501A1 ARP140101106A ARP140101106A AR095501A1 AR 095501 A1 AR095501 A1 AR 095501A1 AR P140101106 A ARP140101106 A AR P140101106A AR P140101106 A ARP140101106 A AR P140101106A AR 095501 A1 AR095501 A1 AR 095501A1
- Authority
- AR
- Argentina
- Prior art keywords
- rsv
- compositions
- proteins
- nucleic acids
- rsv vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente se relaciona con, entre otros, proteínas del virus respiratorio sincicial (RSV), proteínas de RSV modificadas y ácidos nucleicos y vectores que codifican a una o más de ellas. También provee composiciones, incluyendo composiciones inmunogénicas, composiciones farmacéuticas y vacunas. Las composiciones, ácidos nucleicos, vectores y polipéptidos pueden usarse para inducir una respuesta inmune al RSV o a una proteína/s de RSV y/o para tratar o inhibir una infección por RSV en un animal.This is related to, among others, respiratory syncytial virus (RSV) proteins, modified RSV proteins and nucleic acids and vectors encoding one or more of them. It also provides compositions, including immunogenic compositions, pharmaceutical compositions and vaccines. The compositions, nucleic acids, vectors and polypeptides can be used to induce an immune response to RSV or an RSV protein / s and / or to treat or inhibit an RSV infection in an animal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361790263P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095501A1 true AR095501A1 (en) | 2015-10-21 |
Family
ID=56119114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140101106A AR095501A1 (en) | 2013-03-15 | 2014-03-14 | RSV VACCINES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR095501A1 (en) |
-
2014
- 2014-03-14 AR ARP140101106A patent/AR095501A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016016533A (en) | Immunogenic combinations. | |
| AR096113A1 (en) | F PREFUSION POLYPEPTIDES OF RESPIRATORY AND STABILIZED SYNCHRICAL VIRUSES (RSV) | |
| MX2015013065A (en) | Prefusion rsv f proteins and their use. | |
| CO2017006580A2 (en) | Human Antibodies to Influenza Hemagglutinin | |
| MX395525B (en) | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES. | |
| EA201891415A1 (en) | HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION | |
| CY1120740T1 (en) | IMPROVED BLESSING VACCINES | |
| MX389093B (en) | COMPOSITIONS AND METHODS FOR PROTEIN GLYCOSYLATION. | |
| BR112019010275A2 (en) | recombinant adenovirus, composition, use of adenovirus or composition, method of inducing an immune response in a patient, and non-human simian adenovirus | |
| CY1123403T1 (en) | MODIFIED HOST CELLS AND USES THEREOF | |
| MX2017000169A (en) | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection. | |
| PE20190110A1 (en) | RSV PREFUSION F PROTEINS STABILIZED | |
| MX2016006189A (en) | Extract of algae for use as an immunomodulatory agent. | |
| CL2020001901A1 (en) | Influenza virus vaccines and their uses. | |
| MX2017003117A (en) | Flavivirus virus like particle. | |
| MX2015011487A (en) | PROTEIN OF CONSENSUS FOR THE VIRUS OF THE DISEASE OF THE AFTOSA FEVER (FMDV), CODIFICATION SEQUENCES FOR THESE AND VACCINES ELABORATED FROM THESE. | |
| MX2017005687A (en) | METHODS FOR USING FORMULATIONS FOR VACCINES WITH MICROGUJAS TO ELECT IN ANIMALS PROTECTION IMMUNITY AGAINST RABIA VIRUSES. | |
| UY36617A (en) | IMMUNOGENIC FUSION PROTEINS FOR CANCER TREATMENT | |
| BR112015023738B8 (en) | INFLUENZA NUCLEOPROTEIN VACCINES | |
| MX2016000107A (en) | Mammalian milk osteopontin for enhancing immune responsiveness. | |
| BR112017013574A2 (en) | amino acid and peptide conjugates and uses thereof | |
| AR087811A1 (en) | VACCINE AGAINST STAPHYLOCOCCUS AUREUS | |
| EA201592298A1 (en) | HUMAN VIRAL VACCINE AGAINST THE RESPIRATORY SYNCTIAL VIRUS | |
| AR094846A1 (en) | H5 FLU VIRUS PROTEINS H5N1 FOR USE AS A MEDICINAL PRODUCT | |
| EA201592299A1 (en) | HUMAN VIRAL VACCINE AGAINST THE RESPIRATORY SYNCTIAL VIRUS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |